| List | Section | Observation |
|---|---|---|
| PAHO Strategic Fund Medicine List | 13.1. Psychotherapeutic medicines | No observations |
| WHO Model List of Essential Medicines (2021) | 24.1. Medicines used in psychotic disorders | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 24.1. Medicines used in psychotic disorders | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 24.1. Medicines used in psychotic disorders | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 24.1. Medicines used in psychotic disorders | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 24.1. Medicines used in psychotic disorders | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 24.1. Medicines used in psychotic disorders | No observations |
| List | Section | Observation |
|---|---|---|
| Peru | 24.1 Medications for Psychotic Disorders | No observations |
| List | Section | Observation |
|---|---|---|
| Chile | Essential and Prioritized Medications | No observations |